{
  "id": "5874be1975e6e41f",
  "title": "FDA Accepts sBLA for IV Efgartigimod to Treat Patients With AChR - Ab Seronegative gMG",
  "description": "20260113T203000Z",
  "content": "",
  "source": "pharmacytimes.com",
  "source_url": "https://www.pharmacytimes.com/view/fda-accepts-sbla-for-iv-efgartigimod-to-treat-patients-with-achr-ab-seronegative-gmg",
  "published_at": "20260113T203000Z",
  "fetched_at": "2026-01-14T00:24:05.619157+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmacytimes.com/view/fda-accepts-sbla-for-iv-efgartigimod-to-treat-patients-with-achr-ab-seronegative-gmg",
    "url_mobile": "",
    "title": "FDA Accepts sBLA for IV Efgartigimod to Treat Patients With AChR - Ab Seronegative gMG",
    "seendate": "20260113T203000Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/58fb874f3d34873c2522f9e33c5f7e6a8ea654c8-4679x3119.jpg",
    "domain": "pharmacytimes.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}